Article | October 25, 2016

How Many FDA Premarket Applications Are Necessary For Your Combination Product?

Autoinjector-ThinkstockPhotos-518750867

By Girish Kumar, Ph.D., and Prem K. Narang, Ph.D., Camargo Pharmaceutical Services

Often, an already-approved drug can further benefit patients when applied with a medical device. In such cases, the pharmaceutical product sponsor may utilize the 505(b)(2) pathway for regulatory approval of the combination product. But even when the regulatory pathway is known, submission strategies for regulatory approval of combination products can be challenging and confusing. The development and review of combination products in the U.S. typically requires the involvement of multiple centers within the Food and Drug Administration (FDA), under the oversight of the FDA’s Office of Combination Products (OCP).